286 related articles for article (PubMed ID: 16182131)
1. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
Nicholls SJ; Zheng L; Hazen SL
Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
Jin Z; Zhou L; Tian R; Lu N
Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
Shao B; Oda MN; Oram JF; Heinecke JW
Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
[TBL] [Abstract][Full Text] [Related]
6. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
Shao B
Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Lu N; Xie S; Li J; Tian R; Peng YY
Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
[TBL] [Abstract][Full Text] [Related]
8. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
Shao B; Pennathur S; Heinecke JW
J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
[TBL] [Abstract][Full Text] [Related]
10. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
[TBL] [Abstract][Full Text] [Related]
12. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
14. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
Shao B; Heinecke JW
J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
Shao B; Oda MN; Oram JF; Heinecke JW
Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
[TBL] [Abstract][Full Text] [Related]
16. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
Berrougui H; Khalil A
Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
18. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.
Vaisar T; Shao B; Green PS; Oda MN; Oram JF; Heinecke JW
Curr Atheroscler Rep; 2007 Nov; 9(5):417-24. PubMed ID: 18001626
[TBL] [Abstract][Full Text] [Related]
20. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
